Home
|
Print This Page
|
Sitemap
|
Contact
|
Glossary
| Search:
About Us
Meet Our Team
Our Culture
Our Values
History
Message from the CEO
Business Strategy
Strategies
Partnerships
Financing
Therapeutic Programs
Pipeline
Cardiac Muscle Contractility
Skeletal Muscle Contractility
Oncology Program
Our Research
The Cytoskeleton
Muscle Biology
Cell Cycle Control
News and Events
Press Releases
Events Calendar
Scientific and Medical Publications
Investor Relations
Careers
Opportunities
Benefits
Careers FAQ
2013 News Releases
Stock Information
Calendar
Presentations
SEC Filings
Proxy Information
Analyst Coverage
Investor FAQ
IR Contacts
Corporate Governance
Untitled Document
Earnings Estimates
Untitled Document
Information Request
Untitled Document
Email Alerts
Webcast -
Live
Cytokinetics, Inc. Annual Shareholder Meeting
05/22/13
at 1:30 p.m. PT
Cytokinetics, Inc. Annual Shareholder Meeting
Wednesday, May 22, 2013
1:30 p.m. PT
Webcast Presentation
Help
Click here for webcast
Add to Calendar
Help
Javascript must be enabled to use this feature
Click here to add this event to your calendar
Keyword Search
2013 |
2012
|
2011
|
2010
|
2009
Date
Title
05/15/13
Cytokinetics to Hold Annual Meeting of Stockholders
04/30/13
Cytokinetics, Incorporated Reports First Quarter 2013 Financial Results
04/16/13
Cytokinetics to Announce First Quarter Results on April 30, 2013
04/04/13
Cytokinetics Announces Grant From Families with Spinal Muscular Atrophy for Preclinical Development of Tirasemtiv
04/01/13
Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107
03/29/13
Cytokinetics to Present at Upcoming Healthcare Conferences
03/21/13
Cytokinetics Announces Presentation of Phase IIA Clinical Trial Data of Tirasemtiv in Patients with Myasthenia Gravis
03/18/13
Cytokinetics Announces Update to Heart Failure Program
03/13/13
Cytokinetics to Present Clinical Trial Data Relating to Tirasemtiv in Patients with Myasthenia Gravis
03/11/13
Cytokinetics to Present at 25th Annual Roth Conference
02/22/13
Cytokinetics to Present at Upcoming Healthcare Conferences
02/12/13
Cytokinetics Announces Opening of COSMIC-HF, a Phase II Clinical Trial of Oral Formulations of Omecamtiv Mecarbil in Patients with Heart Failure
02/08/13
Cytokinetics to Present at BIO CEO and Investor Conference
02/08/13
Cytokinetics Announces Changes to Its Board of Directors
02/05/13
Cytokinetics, Incorporated Reports Fourth Quarter 2012 Financial Results
01/29/13
Cytokinetics to Announce Fourth Quarter Results on February 5, 2013
01/25/13
Cytokinetics, Incorporated Receives NASDAQ Notice of Minimum Bid Price Compliance
Print Page
|
Email Page
|
RSS Feeds
|
Email Alerts
|
IR Contacts